Pdt Partners, LLC Spring Works Therapeutics, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $459,806 - $607,715	-21,160 Reduced 29.57%	50,387 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $415,363 - $683,540	-17,235 Reduced 19.41%	71,547 $2.04 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $1.63 Million - $5.33 Million	88,782 New	88,782 $2.19 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $1.64 Million - $2.19 Million	-33,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $1.33 Million - $1.89 Million	24,896 Added 289.35%	33,500 $2.08 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $539,126 - $759,389	8,604 New	8,604 $546,000

220

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $1.87B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.